Related Experiment Video
Updated: May 21, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Practice patterns of infectious disease physicians for management of meningococcal disease
Andrew Terranella1, Susan E Beekmann, Philip M Polgreen
1Epidemic Intelligence Service, Scientific, Education, and Professional Development Office, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Background:
Although empiric treatment regimens for acute bacterial meningitis are well established, there are many uncertainties regarding management of meningococcal disease. A survey was conducted among infectious disease specialists to assess meningococcal disease practice patterns and availability of antimicrobial susceptibility testing for Neisseria menigitidis.
Methods:
An online survey was distributed to 1342 pediatric and adult infectious disease specialists to assess common practices and opinions regarding the diagnosis, treatment and prevention of meningococcal disease. Specialists were also asked about the availability of antimicrobial susceptibility testing for Neisseria meningitidis at their clinical microbiology laboratory.
Results:
Six hundred fifty members responded to the survey (48%). Pediatric infectious disease specialists were more likely than adult specialists to use penicillin as definitive therapy for meningococcal disease (56% versus 46%; P = 0.038). Most pediatric specialists who would narrow therapy report that they would only switch to penicillin upon confirmation of penicillin susceptibility (55%), although 44% would narrow therapy based on a N. meningitidis species confirmation alone. More than one third of respondents reported that susceptibility testing for N. meningitidis is not routinely performed. There was also wide variation in complement deficiency screening criteria and meningococcal disease chemoprophylaxis practices among respondents.
Conclusions:
Infectious disease specialists vary significantly in their practices regarding several aspects of meningococcal disease diagnosis, treatment and prevention. Antimicrobial susceptibility testing for N. meningitidis is not routinely performed in many practices. Consideration of these variations would be useful when developing treatment and prevention recommendations.
Insights
Infectious disease specialists show varied practices in managing meningococcal disease, with inconsistent antimicrobial susceptibility testing for Neisseria meningitidis. These differences are important for developing future treatment guidelines.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Practice
Background:
- Management of meningococcal disease presents uncertainties despite established bacterial meningitis treatments.
- Practices and antimicrobial susceptibility testing availability for Neisseria meningitidis were assessed.
Purpose of the Study:
- To evaluate current practice patterns and opinions among infectious disease specialists regarding meningococcal disease.
- To determine the availability of antimicrobial susceptibility testing for Neisseria meningitidis.
Main Methods:
- An online survey was distributed to 1342 pediatric and adult infectious disease specialists.
- The survey covered diagnosis, treatment, prevention, and antimicrobial susceptibility testing for Neisseria meningitidis.
Main Results:
- A 48% response rate (650 specialists) was achieved.
- Significant variations were observed in treatment choices (e.g., penicillin use), species confirmation for therapy adjustment, susceptibility testing availability (over one-third reported it's not routine), complement deficiency screening, and chemoprophylaxis practices.
- Pediatric specialists were more likely to use penicillin than adult specialists.
Conclusions:
- Infectious disease specialists exhibit considerable variation in managing meningococcal disease.
- Routine antimicrobial susceptibility testing for Neisseria meningitidis is lacking in many clinical settings.
- Acknowledging these practice variations is crucial for refining treatment and prevention recommendations.
Related Concept Videos
Bacterial Meningitis I: Introduction
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Atypical Pneumonia
Acute Pyelonephritis II: Diagnostic Studies and Management